Study for integrated traditional Chinese and western medicine in the treatment of the fever period of epidemic hemorrhagic fever
- Conditions
- Epidemic hemorrhagic fever(Hemorrhagic fever with renal syndrome)
- Registration Number
- ITMCTR1900002772
- Lead Sponsor
- onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Comply with the diagnostic criteria for epidemic hemorrhagic fever.
(2) Patients with epidemic hemorrhagic fever in the fifth stage of fever period, body temperature = 38 ° C, and the time of fever should be <=72 h;
(3) Comply with the diagnostic criteria of TCM syndrome (both Wei and Qi Phases);
(4) Aged 18 to 70 years old;
(5) History of allergic reactions without related drugs.
(6) Under the premise of fully understanding the study, voluntarily accept the treatment and detection of the treatment plan of this study, and sign the informed consent form.
(1) Patients with abnormal liver function (AST, ALT exceeds the upper limit of normal by 5 times or more);
(2) Patients with chronic kidney disease;
(3) Combined with serious primary diseases such as cardiovascular and hematopoietic diseases, hematopoietic system, digestive ulcer disease, or serious diseases (such as tumors) that affect their survival;
(4) Those who are allergic to drugs in the Chinese herbal compound;
(5) Pregnant or lactating women;
(6) Mentally or legally disabled patients.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Early intervention to reduce the incidence of critical illness (shock/kidney failure);
- Secondary Outcome Measures
Name Time Method Antipyretic onset time and complete antipyretic time;